First Time Loading...

Northeast Pharmaceutical Group Co Ltd
SZSE:000597

Watchlist Manager
Northeast Pharmaceutical Group Co Ltd Logo
Northeast Pharmaceutical Group Co Ltd
SZSE:000597
Watchlist
Price: 4.66 CNY 1.75% Market Closed
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one Northeast Pharmaceutical Group Co Ltd stock under the Base Case scenario is 8.76 CNY. Compared to the current market price of 4.66 CNY, Northeast Pharmaceutical Group Co Ltd is Undervalued by 47%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
8.76 CNY
Undervaluation 47%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.8
P/S
P/S
Price to Sales
0.8
vs History
95
vs Industry
76
Median 3Y
0.9
Median 5Y
0.9
Industry
2.4
More Details
18
P/E
P/E
Price to Earnings
18
vs History
88
vs Industry
27
Median 3Y
37.8
Median 5Y
37.9
Industry
22.9
More Details
11
P/OCF
P/OCF
Price to OCF
11
vs History
49
vs Industry
34
Median 3Y
8.5
Median 5Y
11
Industry
17.1
More Details
22.9
P/FCFE
P/FCFE
Price to FCFE
22.9
vs History
19
vs Industry
21
Median 3Y
14.7
Median 5Y
10.5
Industry
23.2
More Details
1.3
P/B
P/B
Price to Book Value
1.3
vs History
96
vs Industry
55
Median 3Y
1.6
Median 5Y
1.7
Industry
2.1
More Details
1.2
EV/S
EV/S
Enterprise Value to Sales
1.2
vs History
61
vs Industry
69
Median 3Y
1.2
Median 5Y
1.2
Industry
2.6
More Details
3.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.1
vs History
55
vs Industry
60
Median 3Y
3.1
Median 5Y
3.1
Industry
5.1
More Details
24
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
24
vs History
96
vs Industry
15
Median 3Y
37.5
Median 5Y
38.8
Industry
13.6
More Details
24
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
24
vs History
96
vs Industry
19
Median 3Y
37.5
Median 5Y
38.8
Industry
17
More Details
16.7
EV/OCF
EV/OCF
Enterprise Value to OCF
16.7
vs History
39
vs Industry
27
Median 3Y
11.2
Median 5Y
15.5
Industry
15.8
More Details
27.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
27.9
vs History
28
vs Industry
17
Median 3Y
16.7
Median 5Y
16.9
Industry
17.6
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
96
vs Industry
62
Median 3Y
1
Median 5Y
1
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Northeast Pharmaceutical Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Northeast Pharmaceutical Group Co Ltd
SZSE:000597
6.5B CNY 0.8 18 24 24
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
698B USD 20.4 133.1 60.2 69.1
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 17.1 47.4 34.7 37.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
82T JPY 255.8 9 733.7 1 771.8 4 320.3
US
Johnson & Johnson
NYSE:JNJ
352.2B USD 4.3 8.7 11.6 15.3
US
Merck & Co Inc
NYSE:MRK
332.3B USD 5.5 910.3 45.2 88.3
UK
AstraZeneca PLC
LSE:AZN
186.7B GBP 5.1 39.2 140.6 225.5
CH
Novartis AG
SIX:NOVN
182.5B CHF 4.3 13.4 9.8 16.3
CH
Roche Holding AG
SIX:ROG
176.8B CHF 3 15.4 8.8 10.4

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.